Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Ended earlyNCT04251065
What this trial is testing

Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH

Who this might be right for
Refractory T-Cell LymphomaRelapsed T-Cell Lymphoma
Fondazione Italiana Linfomi - ETS 8
Testing effectiveness (Phase 2)UnknownNCT06224842
What this trial is testing

Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Huijing Wu 30
Testing effectiveness (Phase 2)UnknownNCT04831710
What this trial is testing

Sintilimab in Combination With Chidamide in Refractory and Relapsed AITL

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Sun Yat-sen University 83
Testing effectiveness (Phase 2)Looking for participantsNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Early research (Phase 1)Looking for participantsNCT06393738
What this trial is testing

ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Who this might be right for
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
Arvinas Inc. 255
Not applicableUnknownNCT04319601
What this trial is testing

Rituximab Combined With Chidamide and Lenalidomide for r/r AITL

Who this might be right for
Angioimmunoblastic T-cell LymphomaChemotherapy EffectChemotherapeutic Toxicity
Zhejiang Cancer Hospital 26